Fibromyalgia as a Contextual Factor Influencing Disease Activity Measurements in Spondyloarthritis and Psoriatic Arthritis

REFERENCES

1. 1.↵
   1. Bellato E,
   2. Marini E,
   3. Castoldi F,
   4. Barbasetti N,
   5. Mattei L,
   6. Bonasia DE,
   7. et al.

   Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat 2012;2012:426130.

   OpenUrlPubMed
2. 2.↵
   1. Gran JT

   . The epidemiology of chronic generalized musculoskeletal pain. Best Pract Res Clin Rheumatol 2003;17:547–61.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Wach J,
   2. Letroublon MC,
   3. Coury F,
   4. Tebib JG

   . Fibromyalgia in spondyloarthritis: effect on disease activity assessment in clinical practice. J Rheumatol 2016;43:2056–63.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Brikman S,
   2. Furer V,
   3. Wollman J,
   4. Borok S,
   5. Matz H,
   6. Polachek A,
   7. et al.

   The effect of the presence of fibromyalgia on common clinical disease activity indices in patients with psoriatic arthritis: a cross-sectional study. J Rheumatol 2016;43:1749–54.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Salaffi F,
   2. De Angelis R,
   3. Carotti M,
   4. Gutierrez M,
   5. Sarzi-Puttini P,
   6. Atzeni F

   . Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity. Rheumatol Int 2014;34:1103–10.

   OpenUrlPubMed
6. 6.↵
   1. Coury F,
   2. Rossat A,
   3. Tebib A,
   4. Letroublon MC,
   5. Gagnard A,
   6. Fantino B,
   7. et al.

   Rheumatoid arthritis and fibromyalgia: a frequent unrelated association complicating disease management. J Rheumatol 2009;36:58–62.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Pollard LC,
   2. Kingsley GH,
   3. Choy EH,
   4. Scott DL

   . Fibromyalgic rheumatoid arthritis and disease assessment. Rheumatology 2010;49:924–8.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Kirwan JR,
   2. Boers M,
   3. Hewlett S,
   4. Beaton D,
   5. Bingham CO 3rd,
   6. Choy E,
   7. et al.

   Updating the OMERACT filter: core areas as a basis for defining core outcome sets. J Rheumatol 2014;41:994–9.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Orbai AM,
   2. de Wit M,
   3. Mease P,
   4. Shea J,
   5. Gossec L,
   6. Leung YY,
   7. et al.

   International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials. Ann Rheum Dis 2016 Sep 9 (E-pub ahead of print).
10. 10.↵
    1. Poddubnyy DA,
    2. Rudwaleit M,
    3. Listing J,
    4. Braun J,
    5. Sieper J

    . Comparison of a high sensitivity and standard C reactive protein measurement in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis. Ann Rheum Dis 2010;69:1338–41.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Lee YC,
    2. Hackett J,
    3. Frits M,
    4. Iannaccone CK,
    5. Shadick NA,
    6. Weinblatt ME,
    7. et al.

    Multibiomarker disease activity score and C-reactive protein in a cross-sectional observational study of patients with rheumatoid arthritis with and without concomitant fibromyalgia. Rheumatology 2016;55:640–8.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. da Silva Chakr RM,
    2. Brenol JC,
    3. Behar M,
    4. Mendonca JA,
    5. Kohem CL,
    6. Monticielo OA,
    7. et al.

    Is ultrasound a better target than clinical disease activity scores in rheumatoid arthritis with fibromyalgia? A case-control study. PLoS One 2015;10:e0118620.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Milutinovic S,
    2. Radunovic G,
    3. Veljkovic K,
    4. Zlatanovic M,
    5. Zlatkovic Svenda M,
    6. Perovic Radak M,
    7. et al.

    Development of ultrasound enthesitis score to identify patients with enthesitis having spondyloarthritis: prospective, double-blinded, controlled study. Clin Exp Rheumatol 2015;33:812–7.

    OpenUrlPubMed
14. 14.↵
    1. World Health Organization

    . How to use the ICF: A practical manual for using the International Classification of Functioning, Disability and Health (ICF). Exposure draft for comment. Geneva: WHO; October 2013. [Internet. Accessed September 20, 2016]. Available from: www.who.int/classifications/drafticfpracticalmanual2.pdf?ua=1
15. 15.↵
    1. Boers M,
    2. Kirwan JR,
    3. Tugwell P,
    4. Beaton D,
    5. Bingham CO II,
    6. Conaghan PG,
    7. et al.

    The OMERACT Handbook. 2015. [Internet. Accessed September 20, 2016]. Available from: www.omeract.org/pdf/OMERACT_Handbook.pdf
16. 16.↵
    1. Wolfe F,
    2. Michaud K

    . Outcome and predictor relationships in fibromyalgia and rheumatoid arthritis: evidence concerning the continuum versus discrete disorder hypothesis. J Rheumatol 2009;36:831–6.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Lluch E,
    2. Torres R,
    3. Nijs J,
    4. Van Oosterwijck J

    . Evidence for central sensitization in patients with osteoarthritis pain: a systematic literature review. Eur J Pain 2014;18:1367–75.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Meeus M,
    2. Vervisch S,
    3. De Clerck LS,
    4. Moorkens G,
    5. Hans G,
    6. Nijs J

    . Central sensitization in patients with rheumatoid arthritis: a systematic literature review. Semin Arthritis Rheum 2012;41:556–67.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Kosek E,
    2. Ordeberg G

    . Abnormalities of somatosensory perception in patients with painful osteoarthritis normalize following successful treatment. Eur J Pain 2000;4:229–38.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Andersson ML,
    2. Svensson B,
    3. Bergman S

    . Chronic widespread pain in patients with rheumatoid arthritis and the relation between pain and disease activity measures over the first 5 years. J Rheumatol 2013;40:1977–85.

    OpenUrlAbstract/FREE Full Text